drugset / Trial / NCT05522621

A Muticenter Clinical Study of Chinese Herbal Compound TJAOA102 in Alleviating Menopausal Syndrome

NCT05522621 ↗

Phase 0 Unknown 100 enrolled Tongji Hospital
NaSingle-groupOpen-labelTreatment

Summary

Currently, TCM recipes are widely used in treating menopausal syndrome(MS) with obvious efficiency and slight side effects. We have developed the Chinese herbal compound TJAOA102 and has validated its effects in animals. Here, we will perform a population-based, multicenter study to confirm the safety and efficacy of TJAOA102 in therapy of MS, which will provide a solid evidence for TCM in therapy of MS.

Timeline

Start
2022-10-01
Primary completion
2024-10-01
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject TJAOA102 Traditional medicine (herbal / TCM) 2 unknown Oral

Indications

No indication recorded.